Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD

13.42

+0.03 (0.22%)

Mar 30, 2026, 10:00 AM EDT - Market open

Jade Biosciences Employees

Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.

Employees

55

Change

25

Growth

83.33%

Revenue / Employee

n/a

Profits / Employee

-$1,820,655

Market Cap

661.82M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	55	25	83.33%
Dec 31, 2024	30	-	-

Related Stocks

Company Name	Employees
Gyre Therapeutics	625
MannKind	592
Kura Oncology	260
Arvinas	246
Omeros	202
Solid Biosciences	121
Ocugen	116
Lexicon Pharmaceuticals	81

Employee Rankings

JBIO News

24 days ago - Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
4 weeks ago - Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript - Seeking Alpha
6 weeks ago - Jade Biosciences to Participate in Upcoming Conferences - GlobeNewsWire
2 months ago - Jade Biosciences, Inc. (JBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
3 months ago - Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
3 months ago - Jade Biosciences Announces $45 Million Private Placement - GlobeNewsWire
4 months ago - Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
5 months ago - Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire